Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Lyka Labs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1986 on BSE, Feb 1995 on NSE
Last close ₹76.60up ₹0.35 (0.46%)BSE ₹77.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹76.25.
30 Oct: open ₹77.77, high ₹77.77, low ₹76.60
52-week range of traded prices to 30 Oct 2026
₹44.10Low, 30 Mar 2026₹98.25High, 31 Oct 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹277 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,475
Lyka Labs board meetings
270 filed, newest first. Page 5 of 6.
Mar 2016
Feb 2016
Dec 2015
24 Dec · Board meeting
Nov 2015
Oct 2015
Aug 2015
May 2015
Feb 2015
6 Feb · Board meeting
Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on February 12, 2015 to consider and take on record Unaudited Standalone Financial Results for the Second Quarter ended December 31, 2014. The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled to February 14, 2015.Not held on this date
4 Feb · Board meeting
To consider and take on record Unaudited Standalone Financial Results for the Second Quarter ended December 31, 2014.
Dec 2014
12 Dec · Board meeting
To consider issue of further Shares / Warrants / any other securities on Preferential basis to Promoter / Promoter Group / Others.
Nov 2014
4 Nov · Board meeting
To consider and take on record Unaudited Standalone Financial Results for the First Quarter ended September 30, 2014.
Aug 2014
20 Aug · Board meeting
To consider and take on record Audited Standalone and Consolidated Financial Results for the Fifth Quarter and year of 15 months ended 30.06.2014 and also to consider and take on record Restatement of Accounts for the Financial Year 2012-13.
Jul 2014
14 Jul · Board meeting
3 Jul · Board meeting
To consider : 1) Sale of factory at Tarapur. 2) To approve Notice for seeking approval of Shareholders through Postal Ballot. 3) Appointment of Scrutinizer for Postal Ballot. 4) To decide Calender of Events for Postal Ballot.
May 2014
19 May · Board meeting
For Consideration of Unaudited Financial Results for the Quarter ended March 31, 2014.
Mar 2014
28 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 28, 2014, has decided the following : 1. To re-appoint Shri. N. I. Gandhi as Managing Director for a period of 5 years w.e.f. April 01, 2014 subject to approval of Shareholders in the General Meeting and other Statutory Approvals. 2. To invest in 35,00,000 Equity Shares of Rs. 10/- each of Lyka Exports Limited at a premium of Rs. 25/- in lieu of its outstanding subject to approval of the Shareholders in the General Meeting. 3. To transfer Domestic Marketing Division of Ethical products under Slump Sale to Lyka Healthcare Ltd a wholly owned subsidiary Company w.e.f. March 01, 2014.
Feb 2014
Nov 2013
Oct 2013
30 Oct · Board meeting
To consider and take on record Standalone and Consolidated Financial Results for the Quarter ended September 30, 2013.
Aug 2013
7 Aug · Board meeting
To consider and take on record Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2013.
May 2013
20 May · Board meeting
To consider and take on record Standalone and Consolidated Audited Financial Results for the Quarter and Year ended March 31, 2013.
Feb 2013
5 Feb · Board meeting
To consider and take on record Standalone Un-audited Financial Results and Consolidated Financial Results for the quarter ended December 31, 2012.
Nov 2012
12 Nov · Board meeting
Company had informed the Exchange regarding a Board meeting to be held on November 10, 2012 To consider and take on record Standalone Un-audited Financial Results and Consolidated Financial Results for the quarter ended September 30, 2012.The Company has now informed the Exchange that the aforesaid Board meeting which was Convened on November 10, 2012 is now rescheduled on November 12, 2012.Not held on this date
3 Nov · Board meeting
To consider and take on record Standalone Un-audited Financial Results and Consolidated Financial Results for the quarter ended September 30, 2012.
Aug 2012
24 Aug · Board meeting
For adoption of Annual Accounts for the year ended March 31, 2012.3 Aug · Board meeting
To consider and take on record the Unaudited Financial Results and Consolidated Financial Results for the quarter ended June 30, 2012.
May 2012
4 May · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended March 31, 2012.
Mar 2012
30 Mar · Board meeting
At the Board Meeting held on March 29, 2012 the Board has deferred transfer / sale of the Company's R&D Division to its wholly owned subsidiary Company.26 Mar · Board meeting
To consider transfer / sale of the Company's R&D Centre to its wholly owned subsidiary Company.
Feb 2012
4 Feb · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended December 31, 2011.
Nov 2011
2 Nov · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter September 30, 2011.
Aug 2011
2 Aug · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2011.
May 2011
12 May · Board meeting
Company had informed the Exchange regarding a Board meeting to be held on May 13, 2011 to consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended March 31, 2011. The Company has now informed the Exchange that since the majority of the Directors are not available on May 13, 2011 the Company has therefore adjourned the Board Meeting on May 14, 2011 to consider and take on record Un-audited Standalone and Consolidated Financial Results for the Quarter ended March 31, 2011.5 May · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended March 31, 2011.
Mar 2011
21 Mar · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on March 23, 2011 to consider and take on record the Audited Annual Accounts for the year ended September 30, 2010 and to consider the Consolidated Audited Annual Accounts of the Company for the year ended September 30, 2010. The Company has now informed the Exchange that due to unavoidable circumstances the meeting of the Board of Directors of the Company which was scheduled to be held on March 23, 2011 has been postponed to March 25, 2011.16 Mar · Board meeting
To consider and take on record the Audited Annual Accounts for the year ended September 30, 2010 and to consider the Consolidated Audited Annual Accounts of the Company for the year ended September 30, 2010.
Feb 2011
15 Feb · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended December 31, 2010.
Nov 2010
2 Nov · Board meeting
To consider and take on record the Unaudited Financial Results and also Consolidated Financial Results of the Company for the quarter ended September 30, 2010.
Aug 2010
3 Aug · Board meeting
To consider and take on record the Un-audited Financial Results of the Company for the quarter ended June 30, 2010.
May 2010
6 May · Board meeting
To consider and take on record: 1) Unaudited Financial Results for the quarter ended March 31, 2010. 2) Unaudited financial results of the Company together with that of Lyka BDR International Ltd a Subsidiary for the quarter ended March 31, 2010.